Developing personalized treatments for Alzheimer's disease in diverse populations

HABS-HD - Core C - Clinical Core

NIH-funded research University of North Texas Hlth Sci Ctr · NIH-10916334

This study is looking for people aged 30 and older, especially from African American, Mexican American, and non-Hispanic white backgrounds, to help us find better ways to treat and prevent Alzheimer's disease by sharing their experiences and health information.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of North Texas Hlth Sci Ctr NIH-funded
Lab location1 site (Fort Worth, United States)
Project IDNIH-10916334 on NIH RePORTER

What this research studies

This research focuses on creating tailored treatment and prevention strategies for Alzheimer's disease, particularly among diverse racial and ethnic groups. It involves direct participant interviews, assessments, and imaging to gather comprehensive data from individuals aged 30 and above. The study aims to include a diverse cohort of 3,000 participants, with a specific emphasis on African Americans, Mexican Americans, and non-Hispanic whites, to ensure that findings are relevant to these populations. By analyzing biomarkers and cognitive health, the research seeks to improve understanding and management of Alzheimer's disease.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals aged 30 and older from African American, Mexican American, and non-Hispanic white backgrounds.

Not a fit: Patients who are younger than 30 years old or do not belong to the specified racial/ethnic groups may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more effective and personalized treatment options for Alzheimer's disease, particularly for underrepresented populations.

How similar studies have performed: Previous research has shown success in using population-specific approaches to address health disparities in Alzheimer's disease, making this study a continuation of those efforts.

Where this research is happening

Fort Worth, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.